<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK333439" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK333439/" /><meta name="ncbi_pagename" content="Hereditary Fructose Intolerance - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Hereditary Fructose Intolerance - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Hereditary Fructose Intolerance" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/12/17" /><meta name="citation_author" content="Peter Baker, II" /><meta name="citation_author" content="Lachlan Ayres" /><meta name="citation_author" content="Sommer Gaughan" /><meta name="citation_author" content="James Weisfeld-Adams" /><meta name="citation_pmid" content="26677512" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK333439/" /><meta name="citation_keywords" content="Fructose-bisphosphate aldolase B" /><meta name="citation_keywords" content="ALDOB" /><meta name="citation_keywords" content="Hereditary Fructose Intolerance" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Hereditary Fructose Intolerance" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Peter Baker, II" /><meta name="DC.Contributor" content="Lachlan Ayres" /><meta name="DC.Contributor" content="Sommer Gaughan" /><meta name="DC.Contributor" content="James Weisfeld-Adams" /><meta name="DC.Date" content="2015/12/17" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK333439/" /><meta name="description" content="Following dietary exposure to fructose, sucrose, or sorbitol, untreated hereditary fructose intolerance (HFI) is characterized by metabolic disturbances (hypoglycemia, lactic acidemia, hypophosphatemia, hyperuricemia, hypermagnesemia, hyperalaninemia) and clinical findings (nausea, vomiting, and abdominal distress; chronic growth restriction/failure to thrive). Untreated HFI typically first manifests when fructose- and sucrose-containing foods are introduced in the course of weaning young infants from breast milk. If large quantities of fructose are ingested, the infant may acutely develop lethargy, seizures, and/or progressive coma. Untreated HFI may result in renal and hepatic failure. If identified and treated before permanent organ injury occurs, individuals with HFI can experience a normal quality of life and life expectancy." /><meta name="og:title" content="Hereditary Fructose Intolerance" /><meta name="og:type" content="book" /><meta name="og:description" content="Following dietary exposure to fructose, sucrose, or sorbitol, untreated hereditary fructose intolerance (HFI) is characterized by metabolic disturbances (hypoglycemia, lactic acidemia, hypophosphatemia, hyperuricemia, hypermagnesemia, hyperalaninemia) and clinical findings (nausea, vomiting, and abdominal distress; chronic growth restriction/failure to thrive). Untreated HFI typically first manifests when fructose- and sucrose-containing foods are introduced in the course of weaning young infants from breast milk. If large quantities of fructose are ingested, the infant may acutely develop lethargy, seizures, and/or progressive coma. Untreated HFI may result in renal and hepatic failure. If identified and treated before permanent organ injury occurs, individuals with HFI can experience a normal quality of life and life expectancy." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK333439/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/hfi/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK333439/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C77A8E041FB4100000000042D01A3.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK333439_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK333439_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/folate-mal/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/deafness-overview/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK333439_"><span class="title" itemprop="name">Hereditary Fructose Intolerance</span></h1><p class="contrib-group"><span itemprop="author">Peter Baker, II</span>, MD, FAAP, FACMG, <span itemprop="author">Lachlan Ayres</span>, MB, ChB, MRCP, <span itemprop="author">Sommer Gaughan</span>, RD, CSP, and <span itemprop="author">James Weisfeld-Adams</span>, MB, ChB, FAAP, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK333439_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK333439_ai__"><div class="contrib half_rhythm"><span itemprop="author">Peter Baker, II</span>, MD, FAAP, FACMG<div class="affiliation small">Children's Hospital Colorado<br />University of Colorado School of Medicine<br />Aurora, Colorado<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.odarolocsnerdlihc@rekab.retep" class="oemail">gro.odarolocsnerdlihc@rekab.retep</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Lachlan Ayres</span>, MB, ChB, MRCP<div class="affiliation small">Royal United Hospitals Bath<br />NHS Foundation Trust<br />Bath, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ten.shn@serya.nalhcal" class="oemail">ten.shn@serya.nalhcal</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sommer Gaughan</span>, RD, CSP<div class="affiliation small">Children's Hospital Colorado<br />Aurora, Colorado<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.odarolocsnerdlihc@nahguag.remmos" class="oemail">gro.odarolocsnerdlihc@nahguag.remmos</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">James Weisfeld-Adams</span>, MB, ChB, FAAP, FACMG<div class="affiliation small">Children's Hospital Colorado<br />University of Colorado School of Medicine<br />Aurora, Colorado<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.odarolocsnerdlihc@smada-dlefsiew.semaj" class="oemail">gro.odarolocsnerdlihc@smada-dlefsiew.semaj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 17, 2015</span>.</p><p><em>Estimated reading time: 23 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="hfi.Summary" itemprop="description"><h2 id="_hfi_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Following dietary exposure to fructose, sucrose, or sorbitol, untreated hereditary fructose intolerance (HFI) is characterized by metabolic disturbances (hypoglycemia, lactic acidemia, hypophosphatemia, hyperuricemia, hypermagnesemia, hyperalaninemia) and clinical findings (nausea, vomiting, and abdominal distress; chronic growth restriction/failure to thrive). Untreated HFI typically first manifests when fructose- and sucrose-containing foods are introduced in the course of weaning young infants from breast milk. If large quantities of fructose are ingested, the infant may acutely develop lethargy, seizures, and/or progressive coma. Untreated HFI may result in renal and hepatic failure. If identified and treated before permanent organ injury occurs, individuals with HFI can experience a normal quality of life and life expectancy.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of HFI is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (with suggestive metabolic disturbances and clinical findings following dietary exposure to fructose, sucrose, or sorbitol) who has demonstrated either <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ALDOB</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> or deficient hepatic fructose 1-phosphate aldolase (aldolase B) activity on liver biopsy.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Acute manifestations (e.g., lethargy, seizures, or progressive coma and/or renal and hepatic failure) should be managed symptomatically in a hospital setting, including intravenous glucose (dextrose) administration, supportive treatment of hepatic insufficiency, and treatment of metabolic acidosis, if present.</p><p><i>Prevention of primary manifestations:</i> Dietary restriction of fructose, sucrose, and sorbitol is the cornerstone of HFI treatment. Specific agents to be avoided include fructose, high-fructose corn syrup, honey, agave syrup, inverted sugar, maple-flavored syrup, molasses, palm or coconut sugar, and sorghum. In addition, medicines and formulas in which fructose/sucrose may not be listed as a primary component need to be avoided; examples include syrups, enema solutions, some immunoglobulin solutions, and many infant and pediatric nutritional drinks. During hospitalizations special caution is advised to avoid use of fructose-containing intravenous fluids.</p><p><i>Prevention of secondary complications:</i> Given that reduced fruit and vegetable intake is a dietary requirement, daily supplementation with a "sugar-free" multivitamin is recommended to prevent micronutrient deficiencies, specifically water-soluble vitamins.</p><p><i>Surveillance:</i> No formal guidelines for surveillance exist. Once the diagnosis of HFI has been made, periodic evaluation of liver function, renal function, and growth is reasonable, particularly if compliance with the fructose/sucrose/sorbitol-restricted diet is not absolute.</p><p><i>Agents/circumstances to avoid:</i></p><ul><li class="half_rhythm"><div>Enteral or parenteral exposure to fructose, sorbitol, sucrose, sucralose, and polysorbate.</div></li><li class="half_rhythm"><div>Fructose tolerance testing ("fructose challenge") in the diagnosis of HFI.</div></li></ul><p><i>Evaluation of relatives at risk:</i> Presymptomatic diagnosis and treatment is warranted for sibs at risk in order to avoid life-threatening complications by restriction of fructose intake as soon as possible.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>HFI is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if both <i>ALDOB</i> pathogenic variants have been identified in an affected family member.</p></div></div><div id="hfi.Diagnosis"><h2 id="_hfi_Diagnosis_">Diagnosis</h2><p>There are no formal diagnostic guidelines for hereditary fructose intolerance (HFI).</p><div id="hfi.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Hereditary fructose intolerance (HFI) <b>should be suspected</b> in individuals with the following characteristic metabolic disturbances and clinical findings following dietary exposure to fructose, sucrose, or sorbitol.</p><p><b>Characteristic metabolic disturbances</b></p><ul><li class="half_rhythm"><div>Hypoglycemia (plasma glucose &#x0003c;60 mg/dL; reference range 70-120 mg/dL)</div></li><li class="half_rhythm"><div>Lactic acidemia (plasma lactate &#x0003e;2.5 mmol/L; reference range: 0.5-2.2 mmol/L)</div></li><li class="half_rhythm"><div>Hypophosphatemia</div></li><li class="half_rhythm"><div>Hyperuricemia (plasma uric acid &#x0003e;5.0 mg/dL; reference range 2.0-5.0 mmol/L)</div></li><li class="half_rhythm"><div>Hypermagnesemia</div></li><li class="half_rhythm"><div>Hyperalaninemia</div></li></ul><p><b>Characteristic clinical findings</b></p><ul><li class="half_rhythm"><div>Nausea, vomiting, and abdominal distress</div></li><li class="half_rhythm"><div>Chronic growth restriction/failure to thrive</div></li></ul></div><div id="hfi.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of HFI <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive metabolic disturbances and clinical findings following dietary exposure to fructose, sucrose, or sorbitol who has demonstrated EITHER of the following:</p><ul><li class="half_rhythm"><div>Biallelic pathogenic variants in <i>ALDOB</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (<a class="figpopup" href="/books/NBK333439/table/hfi.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="fighfiTmoleculargenetictestingusedin" rid-ob="figobhfiTmoleculargenetictestingusedin">Table 1</a>)</div></li><li class="half_rhythm"><div>Deficient hepatic fructose 1-phosphate aldolase (aldolase B) activity on liver biopsy</div></li></ul><p>Note: Because of the relatively high <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of <i>ALDOB</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, it is increasingly the preferred confirmatory test for HFI and can obviate the need for liver biopsy.</p><p><b>Molecular testing approaches</b> can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-testing</b></p><ul><li class="half_rhythm"><div><b>Sequence analysis</b> is performed first and followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified.</div></li><li class="half_rhythm"><div><b>Targeted analysis for the following pathogenic variants</b> can be performed first &#x02013; if appropriate &#x02013; in individuals with specific ancestry:</div><ul><li class="half_rhythm"><div>European: p.Ala150Pro and p.Ala175Asp</div></li><li class="half_rhythm"><div>Northern Indian: c.324+1G&#x0003e;A</div></li></ul></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ALDOB</i> and other genes of interest (see <a href="#hfi.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>ALDOB</i>) fails to confirm a diagnosis in an individual with features of hereditary fructose intolerance. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation).</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="hfi.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Hereditary Fructose Intolerance</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK333439/table/hfi.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hfi.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hfi.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_hfi.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_hfi.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_hfi.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALDOB</i></td><td headers="hd_h_hfi.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_hfi.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">66%-100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_hfi.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_hfi.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0%-20%&#x000a0;<sup>6,&#x000a0;7,&#x000a0;8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="hfi.TF.1.1"><p class="no_margin">See <a href="/books/NBK333439/#hfi.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="hfi.TF.1.2"><p class="no_margin">See <a href="#hfi.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="hfi.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="hfi.TF.1.4"><p class="no_margin">The most commonly identified pathogenic variants in European and North American populations are p.Ala150Pro and p.Ala175Asp. The c.324+1G&#x0003e;A splice variant is common in a population from Northern India [<a class="bk_pop" href="#hfi.REF.dursun.2001.523">Dursun et al 2001</a>, <a class="bk_pop" href="#hfi.REF.s_nchezguti_rrez.2002.e56">S&#x000e1;nchez-Guti&#x000e9;rrez et al 2002</a>, <a class="bk_pop" href="#hfi.REF.santer.2005.594">Santer et al 2005</a>, <a class="bk_pop" href="#hfi.REF.gruchota.2006.376">Gruchota et al 2006</a>, <a class="bk_pop" href="#hfi.REF.davitspraul.2008.443">Davit-Spraul et al 2008</a>, <a class="bk_pop" href="#hfi.REF.coffee.2010.33">Coffee et al 2010</a>, <a class="bk_pop" href="#hfi.REF.ferri.2012.31">Ferri et al 2012</a>, <a class="bk_pop" href="#hfi.REF.bijarniamahay.2015.85">Bijarnia-Mahay et al 2015</a>].</p></div></dd><dt>5. </dt><dd><div id="hfi.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="hfi.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#hfi.REF.cross.1990.101">Cross &#x00026; Cox [1990]</a>, <a class="bk_pop" href="#hfi.REF.santer.2005.594">Santer et al [2005]</a>, <a class="bk_pop" href="#hfi.REF.davitspraul.2008.443">Davit-Spraul et al [2008]</a>, <a class="bk_pop" href="#hfi.REF.esposito.2010.1294">Esposito et al [2010]</a></p></div></dd><dt>7. </dt><dd><div id="hfi.TF.1.7"><p class="no_margin">No large deletions were identified by Southern blotting in 56 individuals from Spain [<a class="bk_pop" href="#hfi.REF.s_nchezguti_rrez.2002.e56">S&#x000e1;nchez-Guti&#x000e9;rrez et al 2002</a>].</p></div></dd><dt>8. </dt><dd><div id="hfi.TF.1.8"><p class="no_margin">A large (6.5-kb) intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> with an <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> of 11% was identified in a small Italian cohort [<a class="bk_pop" href="#hfi.REF.ferri.2012.31">Ferri et al 2012</a>].</p></div></dd></dl></div></div></div><p><b>Deficient hepatic fructose 1-phosphate aldolase (aldolase B) activity</b>
<b>on liver biopsy.</b> Specific fructose-1-phosphate aldolase B enzyme assays and fructose assay enzyme panels on frozen liver tissue may be important options for the diagnosis in individuals with clinical and biochemical features of HFI in whom <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> has failed to identify <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>ALDOB</i> pathogenic variants.</p></div></div><div id="hfi.Clinical_Characteristics"><h2 id="_hfi_Clinical_Characteristics_">Clinical Characteristics</h2><div id="hfi.Clinical_Description"><h3>Clinical Description</h3><p>Hereditary fructose intolerance (HFI) typically manifests when fructose- and sucrose-containing foods are introduced in the course of weaning young infants from breast milk [<a class="bk_pop" href="#hfi.REF.ali.1998.353">Ali et al 1998</a>]. Manifestations include nausea, bloating, vomiting, sweating, abdominal pain, and growth retardation [<a class="bk_pop" href="#hfi.REF.odi_vre.1978.605">Odi&#x000e8;vre et al 1978</a>].</p><p>Impaired gluconeogenesis following fructose ingestion may result in acute hypoglycemia that is refractory to glucagon [<a class="bk_pop" href="#hfi.REF.van_den_berghe.1973.637">Van Den Berghe et al 1973</a>]. For example, infants who ingest large quantities of fructose may develop lethargy, seizures, and/or progressive coma, or neonates given a 24% sucrose solution for analgesia during minor procedures may develop hypoglycemia.</p><p>Other biochemical features of HFI include hypermagnesemia, hyperuricemia, hypophosphatemia, and metabolic acidosis [<a class="bk_pop" href="#hfi.REF.bouteldja.2010.105">Bouteldja &#x00026; Timson 2010</a>].</p><p>Other less common findings in HFI include:</p><ul><li class="half_rhythm"><div>Lenticular cataracts, intermittent liver enzyme abnormalities, or chronic liver disease of early or late onset [<a class="bk_pop" href="#hfi.REF.locher.1987.194">Locher 1987</a>, <a class="bk_pop" href="#hfi.REF.krawczy_ski.1994.702">Krawczy&#x00144;ski et al 1994</a>, <a class="bk_pop" href="#hfi.REF.w_ssmann.2000.108">W&#x000f6;ssmann et al 2000</a>, <a class="bk_pop" href="#hfi.REF.ananth.2003.87">Ananth et al 2003</a>];</div></li><li class="half_rhythm"><div>Coagulopathy [<a class="bk_pop" href="#hfi.REF.hoskov_.1977.63">Hoskov&#x000e1; &#x00026; Mrskos 1977</a>];</div></li><li class="half_rhythm"><div>Isolated poor growth [<a class="bk_pop" href="#hfi.REF.mock.1983.764">Mock et al 1983</a>];</div></li><li class="half_rhythm"><div>Intermittent vomiting in the setting of fructose aversion and pristine dentition [<a class="bk_pop" href="#hfi.REF.newbrun.1980.619">Newbrun et al 1980</a>].</div></li></ul><p>Typically, when complete dietary fructose, sucrose, and sorbitol restriction is implemented early in life and adherence is maintained (see Management, <a href="#hfi.Prevention_of_Primary_Manifestations">Prevention of Primary Manifestations</a>), the prognosis for individuals with HFI is excellent (i.e., normal neurocognitive development, health, and life expectancy).</p><p>Conversely, when individuals with HFI do not adhere to recommended dietary restrictions, chronic liver and/or renal disease are expected; however, long-term natural history studies in untreated individuals are lacking [<a class="bk_pop" href="#hfi.REF.odi_vre.1978.605">Odi&#x000e8;vre et al 1978</a>]. Of note, historical reports describe adults with HFI who survived following self-imposed low fructose diets that they refined through trial and error.</p><p>Of note, dental researchers have conflicting observations about oral health in individuals with HFI: one group observed a lower incidence of dental caries and periodontal disease as a result of self-imposed dietary restrictions of sugar [<a class="bk_pop" href="#hfi.REF.marthaler.1967.597">Marthaler &#x00026; Froesch 1967</a>], whereas another group speculated that fructose restriction may itself contribute to periodontal disease as oral microbiome changes appeared to increase the risk for gingival bleeding and calculi in treated individuals [<a class="bk_pop" href="#hfi.REF.sax_n.1989.150">Sax&#x000e9;n et al 1989</a>].</p><p><b>Heterozygotes (carriers)</b> are not at increased risk of developing HFI. While carriers are generally asymptomatic, in older reports hyperuricemia was observed in some presumed or obligate carriers and, thus, these individuals may be predisposed to gout/crystal arthropathy [<a class="bk_pop" href="#hfi.REF.oberhaensli.1987.931">Oberhaensli et al 1987</a>, <a class="bk_pop" href="#hfi.REF.seegmiller.1990.8326">Seegmiller et al 1990</a>].</p></div><div id="hfi.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been identified for HFI; clinical severity and extent of organ damage appear to depend on an individual's nutritional environment.</p></div><div id="hfi.Nomenclature"><h3>Nomenclature</h3><p><a class="bk_pop" href="#hfi.REF.chambers.1956.340">Chambers &#x00026; Pratt [1956]</a> reported "idiosyncrasy to fructose" in a female age 24 years who developed gastrointestinal symptoms and syncopal symptoms following fructose or sugar ingestion.</p><p>"Fructosaemia," a term originally proposed by <a class="bk_pop" href="#hfi.REF.levin.1963.220">Levin et al [1963]</a> to describe the presence of abnormal quantities of fructose in plasma, is now considered obsolete. This finding, which is not specific to HFI, is also observed in fructokinase deficiency and other disorders [<a class="bk_pop" href="#hfi.REF.hommes.1993.788s">Hommes 1993</a>].</p></div><div id="hfi.Prevalence"><h3>Prevalence</h3><p>Hereditary fructose intolerance (HFI) is rare, making precise prevalence estimates challenging.</p><p>European estimates for the prevalence (based on results of <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for common <i>ALDOB</i> pathogenic variants and use of the Hardy-Weinberg principle after correction for the estimated detection rate) are between 1:18,000 and 1:31,000 (<a class="figpopup" href="/books/NBK333439/table/hfi.T.hfi_prevalence_by_population_based/?report=objectonly" target="object" rid-figpopup="fighfiThfiprevalencebypopulationbased" rid-ob="figobhfiThfiprevalencebypopulationbased">Table 2</a>).</p><p>It is important to note that the US study that targeted five specific <i>ALDOB</i> alleles [<a class="bk_pop" href="#hfi.REF.lazarin.2013.178">Lazarin et al 2013</a>] may underestimate the prevalence in persons of non-European ancestry. Applying a Bayesian framework to population-based <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> data, <a class="bk_pop" href="#hfi.REF.schrodi.2015.659">Schrodi et al [2015]</a> devised posterior probability density prevalence estimates for HFI; based on available data, prevalence of HFI was estimated as 1:34,461 (95% credible interval 1:16,800 to 1:94,500).</p><div id="hfi.T.hfi_prevalence_by_population_based" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>HFI Prevalence by Population Based on Carrier Testing for Specific <i>ALDOB</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK333439/table/hfi.T.hfi_prevalence_by_population_based/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hfi.T.hfi_prevalence_by_population_based_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" rowspan="2" colspan="2" scope="colgroup" headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" style="text-align:left;vertical-align:middle;"></th><th id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" style="text-align:left;vertical-align:middle;">UK&#x000a0;<sup>1</sup></th><th id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" style="text-align:left;vertical-align:middle;">Germany&#x000a0;<sup>2</sup></th><th id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" style="text-align:left;vertical-align:middle;">Poland&#x000a0;<sup>3</sup></th><th id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">US</th></tr><tr><th headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5" id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">All&#x000a0;<sup>4</sup></th><th headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5" id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ME&#x000a0;<sup>4</sup></th><th headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5" id="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AA&#x000a0;<sup>4</sup></th></tr></thead><tbody><tr><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Extrapolated HFI prevalence&#x000a0;<sup>5</sup></b></td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1:18,000</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1:26,000</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1:31,000</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1:60,000</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1:38,000</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1:205,000</td></tr><tr><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Variants tested</b></td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala150Pro</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" colspan="3" rowspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">p.Ala175Asp</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" colspan="3" rowspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">p.Asn335Lys</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" colspan="3" rowspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Other</td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_1_5 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_1 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_2 hd_h_hfi.T.hfi_prevalence_by_population_based_1_1_2_3" colspan="3" rowspan="1" style="text-align:left;vertical-align:middle;">p.Tyr205Ter, p.Asn120LysfsTer32</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AA = African American; ME = Middle Eastern</p></div></dd><dt>1. </dt><dd><div id="hfi.TF.2.1"><p class="no_margin">Based on the UK population prevalence of the p.Ala150Pro <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, the final estimate for the incidence of HFI was 1:18,000 live births [<a class="bk_pop" href="#hfi.REF.james.1996.837">James et al 1996</a>]</p></div></dd><dt>2. </dt><dd><div id="hfi.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#hfi.REF.santer.2005.594">Santer et al [2005]</a></p></div></dd><dt>3. </dt><dd><div id="hfi.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#hfi.REF.gruchota.2006.376">Gruchota et al [2006]</a></p></div></dd><dt>4. </dt><dd><div id="hfi.TF.2.4"><p class="no_margin">In a large <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> screening study of multiple disorders in an ethnically diverse population in the United States, overall carrier frequency for an <i>ALDOB</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was 1:122 (~0.8%). Carrier frequencies in persons self-identifying as Middle Eastern (n=388) and African American (n=678) were 1:97 (~1.0%) and 1:226 (~0.4%), respectively. Using the Hardy-Weinberg principle, these data yield disease frequency estimates of 1:60,000 for all the US population, 1:38,000 for US population identified as Middle Eastern, and 1:205,000 for US population identified as African American [<a class="bk_pop" href="#hfi.REF.lazarin.2013.178">Lazarin et al 2013</a>].</p></div></dd><dt>5. </dt><dd><div id="hfi.TF.2.5"><p class="no_margin">Extrapolated prevalence based on detection rate of variants tested</p></div></dd></dl></div></div></div></div></div><div id="hfi.Genetically_Related_Allelic_Disorder"><h2 id="_hfi_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ALDOB</i>.</p></div><div id="hfi.Differential_Diagnosis"><h2 id="_hfi_Differential_Diagnosis_">Differential Diagnosis</h2><p>In addition to hereditary fructose intolerance (HFI), the following disorders should be considered in the evaluation of hepatic insufficiency, unexplained jaundice [<a class="bk_pop" href="#hfi.REF.leonardi.1986.189">Leonardi et al 1986</a>], and hypoglycemia, or in the setting of Reye-like illness in infancy or early childhood [<a class="bk_pop" href="#hfi.REF.yang.2000.218">Yang et al 2000</a>, <a class="bk_pop" href="#hfi.REF.thabet.2002.581">Thabet et al 2002</a>]:</p><ul><li class="half_rhythm"><div>Infectious hepatitis, sepsis, or disseminated intravascular coagulation [<a class="bk_pop" href="#hfi.REF.maggiore.1982.169">Maggiore &#x00026; Borgna-Pignatti 1982</a>]</div></li><li class="half_rhythm"><div>Autoimmune liver disease</div></li><li class="half_rhythm"><div>Neonatal hemochromatosis, which is considered a <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> alloimmune hepatitis</div></li><li class="half_rhythm"><div>Toxic ingestion</div></li><li class="half_rhythm"><div>Hemophagocytic lymphohistiocytosis [<a class="bk_pop" href="#hfi.REF.mandel.1990.267">Mandel et al 1990</a>]</div></li><li class="half_rhythm"><div><a href="/books/n/gene/alpha1-a/">Alpha-1 antitrypsin deficiency</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/tyrosinemia/">Tyrosinemia type 1</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/galactosemia/">Galactosemia</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/ucd-overview/">Urea cycle disorders</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/citrin/">Citrin deficiency</a></div></li><li class="half_rhythm"><div>Fatty acid oxidation disorders (including <a href="/books/n/gene/mcad/">MCAD deficiency</a>, LCHAD deficiency [OMIM <a href="http://omim.org/entry/609016" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609016</a>], and <a href="/books/n/gene/vlcad/">VLCAD deficiency</a>)</div></li><li class="half_rhythm"><div>Organic acidemias</div></li><li class="half_rhythm"><div><a href="/books/n/gene/msud/">Maple syrup urine disease</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/wilson/">Wilson disease</a></div></li><li class="half_rhythm"><div>Hepatic glycogenosis: <a href="/books/n/gene/gsd1/">glycogen storage disease (GSD) types Ia and Ib</a>, <a href="/books/n/gene/gsd3/">GSD III</a>, <a href="/books/n/gene/gsd4/">GSD IV</a>, <a href="/books/n/gene/gsd6/">GSD VI</a>, GSD types IXa1 and IXa2 (OMIM <a href="http://omim.org/entry/306000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">306000</a>), GSD IXb (OMIM <a href="http://omim.org/entry/261750" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">261750</a>), GSD IXc (OMIM <a href="http://omim.org/entry/613027" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613027</a>), and GSD XI (OMIM <a href="http://omim.org/entry/612933" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">612933</a>)</div></li><li class="half_rhythm"><div>Disorders of mitochondrial DNA depletion (including <a href="/books/n/gene/dguok-mtddepl/"><i>DGUOK-</i></a>, <a href="/books/n/gene/mpv17-mtdep/"><i>MPV17-</i></a>, and <a href="/books/n/gene/alpers/"><i>POLG</i></a>-related disorders)</div></li><li class="half_rhythm"><div>Transaldolase deficiency</div></li><li class="half_rhythm"><div><a href="/books/n/gene/cdg/">Congenital disorders of glycosylation</a></div></li></ul><p>In addition to HFI, the following disorders should be considered in the evaluation of infants with hyperlacticemia in combination with hypoglycemia:</p><ul><li class="half_rhythm"><div>Severe infection/sepsis</div></li><li class="half_rhythm"><div>Disorders of gluconeogenesis (including 1,6-fructose bisphosphatase and pyruvate dehydrogenase deficiencies)</div></li><li class="half_rhythm"><div>Fatty acid oxidation disorders (including <a href="/books/n/gene/mcad/">MCAD deficiency</a>, LCHAD deficiency [OMIM <a href="http://omim.org/entry/609016" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609016</a>], and <a href="/books/n/gene/vlcad/">VLCAD deficiency</a>)</div></li><li class="half_rhythm"><div>Organic acidemias</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mt-overview/">Mitochondrial disorders</a></div></li><li class="half_rhythm"><div>Disorders of ketone metabolism (including HMG-CoA-lyase deficiency)</div></li><li class="half_rhythm"><div>Glycogenosis (including glycogen synthase deficiency)</div></li></ul><p>In addition to HFI, the following disorders should be considered in the evaluation of infants with renal Fanconi/aminoaciduria and failure to thrive:</p><ul><li class="half_rhythm"><div>Fanconi-Bickel syndrome (OMIM <a href="http://omim.org/entry/227810" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">227810</a>)</div></li><li class="half_rhythm"><div>Renal tubular acidosis</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mt-overview/">Mitochondrial disorders</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/cdg/">Congenital disorders of glycosylation</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/ctns/">Cystinosis</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/cf/">Cystic fibrosis</a></div></li></ul><p><b>Fructose malabsorption</b> (or "dietary fructose intolerance"), in which fructose transporters in the small intestine are dysfunctional, is distinct from HFI. Symptoms overlap with those observed in HFI and include diarrhea, bloating, and increased flatulence with ingestion of fructose-containing substances. In severe cases, vomiting and abdominal pain may exist, leading to potential confusion with symptoms of HFI. The two disorders can be distinguished clinically by the presence of fructose in the urine in HFI and the presence of fructose in the stool in fructose malabsorption. Hydrogen breath test may be positive in fructose malabsorption; however, this requires oral fructose loading, which is potentially hazardous in the setting of true HFI [<a class="bk_pop" href="#hfi.REF.m_ller.2003.276">M&#x000fc;ller et al 2003</a>]. (See <a href="#hfi.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</a>.)</p><p>Symptoms similar to those of HFI can also be seen in sucrase-isomaltase deficiency (OMIM <a href="http://omim.org/entry/222900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">222900</a>), but simple fructose is well tolerated in that disorder.</p><p>Autoimmune sensitivity to fructose in food protein-induced enterocolitis syndrome (FPIES) has also been reported [<a class="bk_pop" href="#hfi.REF.fiocchi.2014.e602">Fiocchi et al 2014</a>].</p><p><a href="/books/n/gene/cdg/"><b>Type I congenital disorders of glycosylation</b></a> should be considered in the differential diagnosis of HFI [<a class="bk_pop" href="#hfi.REF.adamowicz.2007.407">Adamowicz et al 2007</a>, <a class="bk_pop" href="#hfi.REF.pronicka.2007.101">Pronicka et al 2007</a>] due in part to the overlap in symptoms (including potential for hepatic insufficiency, failure to thrive, and aminoaciduria/renal Fanconi syndrome), but, more importantly, because HFI causes a secondary disorder of glycosylation [<a class="bk_pop" href="#hfi.REF.quintana.2009.s273">Quintana et al 2009</a>] reflecting inhibitory effects of fructose-1-phosphate on phosphomannose isomerase [<a class="bk_pop" href="#hfi.REF.jaeken.1996.764">Jaeken et al 1996</a>]. In HFI, clinical analysis of transferrin glycosylation may be positive, and should correct once fructose is adequately restricted and liver disease subsides. The pattern of abnormal glycosylation is not characteristic of a particular glycosylation defect, and sequencing of <i>ALDOB</i> or enzyme analysis in liver should be considered in instances where there is clinical suspicion for HFI. It should also be noted that in individuals who self-restrict fructose, quantifiable glycosylation abnormalities may resolve spontaneously, and thus transferrin glycosylation should be used with caution and not in isolation in the diagnosis of HFI.</p><p><b>Other</b></p><ul><li class="half_rhythm"><div>In addition to HFI, the following disorders should be considered in the evaluation of adult- or childhood-onset of chronic liver disease: infection, toxic ingestion, and neoplasm.</div></li><li class="half_rhythm"><div>In addition to HFI, the following disorders should be considered in the evaluation of infantile/childhood-onset unexplained vomiting: gastroesophageal reflux, pyloric stenosis, <a href="/books/n/gene/ucd-overview/">urea cycle disorders</a>, or <a href="/books/n/gene/gale-def/">galactose epimerase deficiency</a>.</div></li><li class="half_rhythm"><div>In children or adults with early-onset and unexplained cataracts, <a href="/books/n/gene/ctx/">cerebrotendinous xanthomatosis</a> or galactokinase deficiency (OMIM <a href="http://omim.org/entry/230200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">230200</a>) should be considered.</div></li><li class="half_rhythm"><div>The co-occurrence of HFI and other conditions (e.g., <a href="/books/n/gene/pku/">phenylketonuria</a>, <a href="/books/n/gene/celiac/">celiac disease</a>, and <a href="/books/n/gene/dbmd/">Duchenne muscular dystrophy</a>) have delayed diagnosis and/or initiation of treatment of HFI in some instances [<a class="bk_pop" href="#hfi.REF.celiker.1993.127">Celiker et al 1993</a>, <a class="bk_pop" href="#hfi.REF.ciacci.2006.635">Ciacci et al 2006</a>, <a class="bk_pop" href="#hfi.REF.paolella.2012.64">Paolella et al 2012</a>].</div></li></ul></div><div id="hfi.Management"><h2 id="_hfi_Management_">Management</h2><div id="hfi.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with hereditary fructose intolerance (HFI), evaluation by the following specialists is recommended:</p><ul><li class="half_rhythm"><div>Biochemical geneticist or pediatrician with an interest in metabolic disorders</div></li><li class="half_rhythm"><div>Dietician with experience in managing inherited metabolic diseases</div></li><li class="half_rhythm"><div>Hepatologist</div></li><li class="half_rhythm"><div>Nephrologist</div></li><li class="half_rhythm"><div>Clinical geneticist and/or genetic counselor</div></li></ul></div><div id="hfi.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Acute presentations should be managed symptomatically in a hospital setting, including intravenous glucose (dextrose) administration, supportive treatment of hepatic insufficiency (including fresh frozen plasma or exchange transfusion), and treatment of metabolic acidosis, if present.</p><p>Dietary restriction of fructose, sucrose, and sorbitol is the cornerstone of HFI treatment (see <a href="#hfi.Prevention_of_Primary_Manifestations">Prevention of Primary Manifestations</a>). During acute episodes of intoxication, including at the time of initial diagnosis, immediate and absolute elimination of fructose (by substitution of fructose with other carbohydrate sources including glucose, maltose, and cornstarch) rapidly reverses symptoms and should result in normalization of related metabolic disturbances.</p><p>Ongoing education for children and adults concerning the need for dietary restriction is recommended, and should ideally be handled by nutritionists with specific experience in treating HFI and other inherited metabolic diseases.</p><p>Individuals with HFI are advised to wear a medically approved alert bracelet/necklace at all times.</p><p>Hepatomegaly with steatosis and lipid vacuolization may remain a persistent complication despite fructose restriction and resolution of initial fibrosis. This includes individuals ascertained by family history and treated from birth [<a class="bk_pop" href="#hfi.REF.odi_vre.1978.605">Odi&#x000e8;vre et al 1978</a>]. The reason for this remains to be determined, but may be related to insufficient fructose restriction as well as lower tolerance of fructose early in life [<a class="bk_pop" href="#hfi.REF.froesch.1963.151">Froesch et al 1963</a>].</p><p>Chronic renal insufficiency, specifically proximal tubular dysfunction, may also persist despite fructose restriction. Typically resolution of renal disease occurs shortly after starting fructose restriction [<a class="bk_pop" href="#hfi.REF.odi_vre.1978.605">Odi&#x000e8;vre et al 1978</a>]. In rare historical instances, dietary modification did not affect renal dysfunction [<a class="bk_pop" href="#hfi.REF.mass.1966.516">Mass et al 1966</a>, <a class="bk_pop" href="#hfi.REF.morris.1968.1648">Morris 1968</a>]. This may be a result of earlier, incomplete attempts at restriction, as reported patients tended to manage themselves with self-restriction alone. It may also be in part due to primary defects in aldolase function and ATPase interaction within the proximal tubule, leading to dysfunctional acid-base regulation, renal tubular insufficiency (manifesting as glucosuria, aminoaciduria, and phosphaturia), and nephrocalcinosis [<a class="bk_pop" href="#hfi.REF.mass.1966.516">Mass et al 1966</a>, <a class="bk_pop" href="#hfi.REF.morris.1968.1648">Morris 1968</a>, <a class="bk_pop" href="#hfi.REF.lu.2001.30407">Lu et al 2001</a>, <a class="bk_pop" href="#hfi.REF.steinmann.2011">Steinmann &#x00026; Santer 2011</a>].</p></div><div id="hfi.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>Dietary restriction of fructose, sucrose, and sorbitol is necessary for the treatment/management of HFI (<a class="figpopup" href="/books/NBK333439/table/hfi.T.dietary_guidelines_for_hereditary/?report=objectonly" target="object" rid-figpopup="fighfiTdietaryguidelinesforhereditary" rid-ob="figobhfiTdietaryguidelinesforhereditary">Table 3</a>).</p><p>Specific ingredients to avoid include fructose, high-fructose corn syrup, honey, agave syrup, inverted sugar, maple-flavored syrup, molasses, palm or coconut sugar, and sorghum.</p><p>In addition, medicines and formulas in which fructose/sucrose may not be listed as a primary component, examples of which include syrups, enema solutions, some immunoglobulin solutions, and many infant and pediatric nutritional drinks. When ingredients are listed, the terms "sugar," "table sugar," "natural flavorings," and even in some cases "sugar-free" or "no added sugar" (with no further clarification on the type of carbohydrate used) should raise suspicion for the presence of fructose, sucrose, or sorbitol.</p><div id="hfi.T.dietary_guidelines_for_hereditary" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Dietary Guidelines for Hereditary Fructose Intolerance (HFI)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK333439/table/hfi.T.dietary_guidelines_for_hereditary/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hfi.T.dietary_guidelines_for_hereditary_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Food Category</th><th id="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Foods Permitted</th><th id="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Foods Prohibited</th></tr></thead><tbody><tr><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dairy</b></td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Any milk, cheese, eggs</td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Milk products w/added sugar (sweetened yogurt, fruit yogurt, milkshake, chocolate milk)</td></tr><tr><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Meat</b></td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Beef, veal, lamb, pork</td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ham, bacon, hot dogs, processed meats; any other meat where sugar is used in processing</td></tr><tr><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Fish</b></td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All fish</td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td></tr><tr><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Poultry</b></td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chicken, turkey</td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td></tr><tr><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cereal</b></td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cooked or ready-to-eat cereals (except sweetened &#x00026; sugar-coated cereals)</td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sweetened/sugar-coated cereals</td></tr><tr><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Fruit</b></td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All fruits, fruit juices, including squashes &#x00026; cordials, &#x00026; fruit extracts prohibited</td></tr><tr><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Vegetables</b></td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Asparagus, cabbage, cauliflower, celery, green beans, green peppers, lettuce, nuts, onions, potatoes, spinach, wax beans</td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All other vegetables, including sweet potatoes</td></tr><tr><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Bread</b></td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Breads prepared w/out fructose, sucrose, sugar, or sorbitol; soda crackers &#x00026; saltines</td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Any breads or crackers prepared w/fructose/sucrose/sugar/sorbitol</td></tr><tr><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Fat sources</b></td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Butter, margarine, oil, mayonnaise / mustard prepared w/out sugar</td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mayonnaises, mustards, &#x00026; salad dressings made with sugar</td></tr><tr><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Desserts and sweeteners</b></td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dietetic jello, dietetic ice cream, dietetic puddings; natural yogurt; glucose, dextrose, dextrin, maltose &#x00026; zero-calorie sweeteners</td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All desserts containing sugar (cake, pie, cookies, candy, jello, ice cream, sherbet, honey, fruit juice); sugar, sucrose, sorbitol, fructose</td></tr><tr><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous</b></td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vegetable juices, coffee, tea, salt, pepper, broths/soups from permitted vegetables; some sugar substitutes; some dietetic beverages; pasta; rice; cinnamon, garlic, poppy seeds; peanut butter (when pure &#x00026; w/out added sugars)</td><td headers="hd_h_hfi.T.dietary_guidelines_for_hereditary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ketchup &#x00026; any other sauces / condiments containing sugar, jam, jelly, preserves, carbonated beverages / soda; peanut butter if prepared w/added sugars; chewing gum w/sorbitol</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Adapted from <a href="http://www.bu.edu/aldolase/HFI/treatment/sugar_table.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www<wbr style="display:inline-block"></wbr>​.bu.edu/aldolase/HFI<wbr style="display:inline-block"></wbr>​/treatment/sugar_table.htm</a></p></div></dd></dl></div></div></div><p>During hospitalizations special caution should be taken to avoid use of fructose-containing intravenous fluids. A number of reported accidental and iatrogenic fructose infusion-related deaths have prompted greater awareness of HFI [<a class="bk_pop" href="#hfi.REF.locher.1987.194">Locher 1987</a>, <a class="bk_pop" href="#hfi.REF.sachs.1993.56">Sachs et al 1993</a>, <a class="bk_pop" href="#hfi.REF.curran.2002.112">Curran &#x00026; Havill 2002</a>, <a class="bk_pop" href="#hfi.REF.m_ller.2003.276">M&#x000fc;ller et al 2003</a>]; however, with a rare disorder such as HFI and in circumstances in which specific dietary (and infusion) restrictions may not be adequately disclosed, the danger of exposure in a hospital setting remains [<a class="bk_pop" href="#hfi.REF.cox.1993.413">Cox 1993</a>]. The following are recommendations:</p><ul><li class="half_rhythm"><div>During any hospitalization, all members of the care team should be aware of the diagnosis of HFI and the patient is advised to wear at all times a medically approved alert bracelet/necklace that provides information about the diagnosis of HFI.</div></li><li class="half_rhythm"><div>"Red flags" should be placed in the patient's chart or medical record to alert practitioners to the HFI diagnosis and to medical risks associated with exposures to foods and/or medications (oral or parenteral) containing fructose, sucrose, or sorbitol.</div></li><li class="half_rhythm"><div>Specific medicines known to contain fructose or fructose-like substances should be avoided.</div></li><li class="half_rhythm"><div>For parenteral medications, hospital pharmacists should be utilized and medications should be cleared for use on a case-by-case basis.</div></li><li class="half_rhythm"><div>Oral fructose challenge is no longer considered a favorable approach to diagnosis of HFI.</div></li></ul><p>Dietary restriction should be strictly followed and maintained, especially in infancy. Although some have suggested that after age two years dietary restrictions can be relaxed somewhat [<a class="bk_pop" href="#hfi.REF.steinmann.2011">Steinmann &#x00026; Santer 2011</a>], currently, there are no specific guidelines regarding dietary fructose limits in any age group.</p><p>Tolerance of dietary fructose probably depends on an individual's residual enzyme activity. Furthermore, because actual fructose content in foods may be unreliably reported or difficult to ascertain, adherence to complete dietary restriction of fructose, sucrose, and sorbitol may be difficult attain and unrealistic for some patients with HFI.</p></div><div id="hfi.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Ensuring adequate vitamin supplementation in the setting of reduced fruit and vegetable intake is imperative. Daily supplementation with a "sugar-free" multivitamin is recommended to prevent micronutrient deficiencies, specifically the water-soluble vitamins.</p></div><div id="hfi.Surveillance"><h3>Surveillance</h3><p>There are no formal guidelines for surveillance for individuals with HFI (e.g., frequency of subspecialty visits with physicians and/or dieticians with expertise in management of inherited metabolic diseases).</p><p>Once the diagnosis of HFI has been made, periodic evaluation of liver function, renal function, and growth is reasonable, particularly if there are concerns regarding compliance with the fructose/sucrose/sorbitol-restricted diet.</p><p>While <a class="def" href="/books/n/gene/glossary/def-item/isoelectric-focusing/">isoelectric focusing</a> of transferrin and/or monitoring of aspartylglucosaminidase (elevated in untreated HFI) have been suggested as markers of disease control in HFI, neither of these clinically available tests has definitively proven utility in diagnosis or surveillance [<a class="bk_pop" href="#hfi.REF.pronicka.2007.101">Pronicka et al 2007</a>, <a class="bk_pop" href="#hfi.REF.michelakakis.2009.81">Michelakakis et al 2009</a>, <a class="bk_pop" href="#hfi.REF.quintana.2009.s273">Quintana et al 2009</a>].</p></div><div id="hfi.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Great care should be taken to avoid enteral or parenteral exposure to fructose, sorbitol, sucrose, sucralose, and polysorbate as administration of these substances to individuals with HFI can be fatal.</p><p>The following resources can be valuable in determining medical and dietary safety.</p><ul><li class="half_rhythm"><div>Dietary guidance &#x02013;including prohibited foods- is outlined in <a class="figpopup" href="/books/NBK333439/table/hfi.T.dietary_guidelines_for_hereditary/?report=objectonly" target="object" rid-figpopup="fighfiTdietaryguidelinesforhereditary" rid-ob="figobhfiTdietaryguidelinesforhereditary">Table 3</a>.</div></li><li class="half_rhythm"><div>An extensive list of tolerated and non-tolerated sugars in HFI can be found <a href="http://www.bu.edu/aldolase/HFI/treatment/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>, a site curated by the Boston University HFI laboratory.</div></li><li class="half_rhythm"><div>Although there is no single consolidated list of medications that contain these or related sugars, an advanced search on <a href="http://www.medicines.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.medicines.org.uk</a> using the search term "fructose OR sorbitol OR sucrose OR sucralose" yielded 1776 results. Many such medications are oral suspensions or chewable flavored tabs designed for pediatric use. Also listed were injectable medications like immunoglobulin solutions (e.g., trastuzumab, filgrastim, some intravenous immunoglobulin solutions), vaccines (e.g., certain influenza, meningococcal), and iron supplements, as well as enema solutions and rinsing aids. For many preparations, it may not be apparent that fructose or similar compounds are present.</div></li><li class="half_rhythm"><div>For parenteral medications, hospital pharmacists should clear use of medications on a case-by-case basis. Of particular note, a 24% sucrose solution (routinely administered to hospitalized neonates for minor procedures) <b>should</b>
<b>not be given</b> to neonates known to have HFI.</div></li><li class="half_rhythm"><div>The fructose tolerance testing ("fructose challenge") to diagnose HFI can be hazardous and should not be used.</div></li></ul></div><div id="hfi.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It may be appropriate to evaluate apparently asymptomatic older and younger sibs in order to identify individuals who would benefit from fructose restriction (see <a href="#hfi.Prevention_of_Primary_Manifestations">Prevention of Primary Manifestations</a>). If the <i>ALDOB</i> pathogenic variants in the family are known, targeted <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk family members.</p><p>See <a href="#hfi.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="hfi.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Few reports exist relating to management of pregnant women with HFI or pregnancy-related complications in HFI. In general, in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> reports in which pregnancies are not expressly discussed, it appears that HFI in a pregnant mother does not cause harm to the mother or the child provided that strict fructose avoidance is followed during the pregnancy.</p><p>In one family a woman with enzymatically documented HFI had three children (presumably from the same father), all of whom also had HFI [<a class="bk_pop" href="#hfi.REF.marks.1989.362">Marks et al 1989</a>]. Most complications observed in these children seem to have resulted from their own poorly controlled HFI or comorbidities in early childhood, rather than maternal effects of HFI per se. The first child developed failure to thrive and cirrhosis and died at age six months of <i>E coli</i> sepsis and pulmonary edema. The second child, who had HFI complicated by transfusion-acquired HIV infection, died at age five years from complications of acquired immunodeficiency syndrome (AIDS). In her third pregnancy, which proceeded normally, the mother was maintained on a strict fructose-restricted diet. The child also had HFI but thrived on a fructose-restricted diet.</p></div><div id="hfi.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="hfi.Genetic_Counseling"><h2 id="_hfi_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="hfi.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Hereditary fructose intolerance (HFI) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="hfi.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>ALDOB</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are generally asymptomatic and are not at risk of developing HFI (see <a href="#hfi.Clinical_Description">Clinical Description</a>, <b>Heterozygotes</b>).</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing HFI (see <a href="#hfi.Clinical_Description">Clinical Description</a>, <b>Heterozygotes</b>).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Unless an individual with HFI has children with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual or a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, his/her offspring will be obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ALDOB</i> (see <a href="#hfi.Clinical_Description">Clinical Description</a>, <b>Heterozygotes</b>).</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ALDOB</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="hfi.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>ALDOB</i> pathogenic variants in the family.</p></div><div id="hfi.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#hfi.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk sibs for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="hfi.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ALDOB</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for HFI are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="hfi.Resources"><h2 id="_hfi_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000359.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Fructose Intolerance</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/hereditary-fructose-intolerance" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary fructose intolerance</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="hfi.Molecular_Genetics"><h2 id="_hfi_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="hfi.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Hereditary Fructose Intolerance: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK333439/table/hfi.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hfi.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_hfi.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_hfi.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_hfi.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_hfi.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_hfi.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_hfi.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_hfi.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/229" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ALDOB</i></a></td><td headers="hd_b_hfi.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=229" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q31<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_hfi.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P05062" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fructose-bisphosphate aldolase B</a></td><td headers="hd_b_hfi.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.bu.edu/aldolase/HFI/hfidb/hfidb.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Fructose Intolerance Mutational Database</a><br /><a href="http://databases.lovd.nl/shared/genes/ALDOB" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALDOB database</a></td><td headers="hd_b_hfi.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ALDOB" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALDOB</a></td><td headers="hd_b_hfi.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ALDOB[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ALDOB</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="hfi.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="hfi.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Hereditary Fructose Intolerance (<a href="/omim/229600,612724" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK333439/table/hfi.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hfi.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/229600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">229600</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FRUCTOSE INTOLERANCE, HEREDITARY</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612724" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612724</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ALDOLASE B, FRUCTOSE-BISPHOSPHATE; ALDOB</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>ALDOB</i> has nine exons and spans a DNA segment of 14.5 kb. ALDOB <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> encodes a 364-amino acid polypeptide; 5' flanking sequences (up to 200 base pairs) of <i>ALDOB</i> from different species are highly conserved. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK333439/#hfi.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Approximately 60 different <i>ALDOB</i> pathogenic variants have been described and are cataloged in the Human Gene Mutation Database (HGMD). Types of pathogenic variants include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and splice-site variants, small insertions and deletions that result in a shift of the reading frame, and several large deletions (see <a class="figpopup" href="/books/NBK333439/table/hfi.T.aldob_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="fighfiTaldobpathogenicvariantsdiscusse" rid-ob="figobhfiTaldobpathogenicvariantsdiscusse">Table 4</a>).</p><p>The spectrum and <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> of various pathogenic <i>ALDOB</i> alleles has been described mostly in European and North American populations with HFI [<a class="bk_pop" href="#hfi.REF.s_nchezguti_rrez.2002.e56">S&#x000e1;nchez-Guti&#x000e9;rrez et al 2002</a>, <a class="bk_pop" href="#hfi.REF.santer.2005.594">Santer et al 2005</a>, <a class="bk_pop" href="#hfi.REF.gruchota.2006.376">Gruchota et al 2006</a>, <a class="bk_pop" href="#hfi.REF.davitspraul.2008.443">Davit-Spraul et al 2008</a>, <a class="bk_pop" href="#hfi.REF.coffee.2010.33">Coffee et al 2010</a>, <a class="bk_pop" href="#hfi.REF.ferri.2012.31">Ferri et al 2012</a>]:</p><ul><li class="half_rhythm"><div>p.Ala150Pro: 44%-67%</div></li><li class="half_rhythm"><div>p.Ala175Asp: 0%-19%</div></li><li class="half_rhythm"><div>p.Asn335Lys: 0%-8%</div></li><li class="half_rhythm"><div>p.Arg60Ter: 0%-4%</div></li><li class="half_rhythm"><div>p.Asn120LysfsTer32 ("delta E4E" <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>): 4%</div></li><li class="half_rhythm"><div>6.5-kb intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>: 11% <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> in Italians</div></li></ul><p>The c.324+1G&#x0003e;A <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variant accounted for 59% of <i>ALDOB</i> pathogenic variants in a small cohort of North Indian patients diagnosed and managed in New Delhi. Several other novel pathogenic variants were also reported in this population [<a class="bk_pop" href="#hfi.REF.bijarniamahay.2015.85">Bijarnia-Mahay et al 2015</a>].</p><div id="hfi.T.aldob_pathogenic_variants_discusse" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>ALDOB</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK333439/table/hfi.T.aldob_pathogenic_variants_discusse/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hfi.T.aldob_pathogenic_variants_discusse_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias)&#x000a0;<sup>1</sup></th><th id="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.178C&#x0003e;T</td><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg60Ter</td><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000035.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000035<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_000026.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000026<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.324+1G&#x0003e;A</td><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.360_363delCAAA</td><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn120LysfsTer32<br />(delta E4E)</td></tr><tr><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.448G&#x0003e;C</td><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala150Pro</td></tr><tr><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.524C&#x0003e;A</td><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala175Asp</td></tr><tr><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.865delC</td><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu288PhefsTer10</td></tr><tr><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1005C&#x0003e;G</td><td headers="hd_h_hfi.T.aldob_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p. Asn335Lys</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors.&#x000a0;<i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="hfi.TF.4.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Functional aldolase B enzyme (the protein product of <i>ALDOB</i>) is a 160-kd tetramer consisting of four identical subunits; it has similar activity with fructose 1,6 bisphosphate and fructose 1-phosphate. The single primary transcript undergoes alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> to give rise to the three isozyme-specific aldolases with variable carboxy-terminal sequencing and differing catalytic properties [<a class="bk_pop" href="#hfi.REF.ali.1998.353">Ali et al 1998</a>]. Together with fructokinase and triokinase, aldolase B participates in fructose metabolism, mostly in the liver, renal cortex, and intestinal mucosa. Aldolase B splits fructose-1-phosphate into dihydroxyacetone phosphate and glyceraldehyde. Hepatic formation of glycogen from fructose is principally catalyzed by aldolase B.</p><p>In normal individuals, aldolase B rapidly converts intravenous fructose to glucose resulting in hyperglycemia; fructose may also be converted to lactate, provoking metabolic acidosis. For these reasons, the use of fructose, sucrose, or sorbitol has been discouraged as a constituent of parenteral nutrition in general.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> HFI results from loss of aldolase B function. The p.Ala150Pro <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is known to be more thermolabile than the <a class="def" href="/books/n/gene/glossary/def-item/wild-type/">wild-type</a> protein [<a class="bk_pop" href="#hfi.REF.malay.2005.135">Malay et al 2005</a>]. Partial misfolding with consequent loss of activity is a common feature in inherited metabolic diseases. Accumulation of fructose-1-phosphate in the setting of diminished aldolase B function inhibits gluconeogenesis and glycogenolysis, causes overutilization and diminished regeneration of ATP, and impairs protein glycosylation.</p></div><div id="hfi.References"><h2 id="_hfi_References_">References</h2><div id="hfi.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.adamowicz.2007.407">Adamowicz M, P&#x00142;oski R, Rokicki D, Morava E, Gizewska M, Mierzewska H, Pollak A, Lefeber DJ, Wevers RA, Pronicka E. Transferrin hypoglycosylation in hereditary fructose intolerance: using the clues and avoiding the pitfalls. <span><span class="ref-journal">J Inherit Metab Dis. </span>2007;<span class="ref-vol">30</span>:407.</span> [<a href="/pubmed/17457694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17457694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.ali.1998.353">Ali M, Rellos P, Cox TM. Hereditary fructose intolerance. <span><span class="ref-journal">J Med Genet. </span>1998;<span class="ref-vol">35</span>:353–65.</span> [<a href="/pmc/articles/PMC1051308/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051308</span></a>] [<a href="/pubmed/9610797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9610797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.ananth.2003.87">Ananth N, Praveenkumar GS, Rao KA. Vasanthi, Kakkilaya S. Two cases of hereditary fructose intolerance. <span><span class="ref-journal">Indian J Clin Biochem. </span>2003;<span class="ref-vol">18</span>:87–92.</span> [<a href="/pmc/articles/PMC3453872/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3453872</span></a>] [<a href="/pubmed/23105397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23105397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.bijarniamahay.2015.85">Bijarnia-Mahay S, Movva S, Gupta N, Sharma D, Puri RD, Kotecha U, Saxena R, Kabra M, Mohan N, Verma IC. Molecular diagnosis of hereditary fructose intolerance: founder mutation in a community from India. <span><span class="ref-journal">JIMD Rep. </span>2015;<span class="ref-vol">19</span>:85–93.</span> [<a href="/pmc/articles/PMC4501232/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4501232</span></a>] [<a href="/pubmed/25595217" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25595217</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.bouteldja.2010.105">Bouteldja N, Timson DJ. The biochemical basis of hereditary fructose intolerance. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010;<span class="ref-vol">33</span>:105–12.</span> [<a href="/pubmed/20162364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20162364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.celiker.1993.127">Celiker V, Dural O, Erdem K. Anesthetic management of a patient with hereditary fructose intolerance and phenylketonuria. <span><span class="ref-journal">Turk J Pediatr. </span>1993;<span class="ref-vol">35</span>:127–30.</span> [<a href="/pubmed/8249192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8249192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.chambers.1956.340">Chambers RA, Pratt RT. Idiosyncrasy to fructose. <span><span class="ref-journal">Lancet. </span>1956;<span class="ref-vol">271</span>:340.</span> [<a href="/pubmed/13358219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13358219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.ciacci.2006.635">Ciacci C, Gennarelli D, Esposito G, Tortora R, Salvatore F, Sacchetti L. Hereditary fructose intolerance and celiac disease: a novel genetic association. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2006;<span class="ref-vol">4</span>:635–8.</span> [<a href="/pubmed/16630753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16630753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.coffee.2010.33">Coffee EM, Yerkes L, Ewen EP, Zee T, Tolan DR. Increased prevalence of mutant null alleles that cause hereditary fructose intolerance in the American population. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010;<span class="ref-vol">33</span>:33–42.</span> [<a href="/pmc/articles/PMC2954661/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2954661</span></a>] [<a href="/pubmed/20033295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20033295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.cox.1993.413">Cox TM. Iatrogenic deaths in hereditary fructose intolerance. <span><span class="ref-journal">Arch Dis Child. </span>1993;<span class="ref-vol">69</span>:413–5.</span> [<a href="/pmc/articles/PMC1029544/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1029544</span></a>] [<a href="/pubmed/8259868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8259868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.cross.1990.101">Cross NC, Cox TM. Partial aldolase B gene deletions in hereditary fructose intolerance. <span><span class="ref-journal">Am J Hum Genet. </span>1990;<span class="ref-vol">47</span>:101–6.</span> [<a href="/pmc/articles/PMC1683764/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1683764</span></a>] [<a href="/pubmed/2349937" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2349937</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.curran.2002.112">Curran BJ, Havill JH. Hepatic and renal failure associated with amiodarone infusion in a patient with hereditary fructose intolerance. <span><span class="ref-journal">Crit Care Resusc. </span>2002;<span class="ref-vol">4</span>:112–5.</span> [<a href="/pubmed/16573414" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16573414</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.davitspraul.2008.443">Davit-Spraul A, Costa C, Zater M, Habes D, Berthelot J, Brou&#x000e9; P, Feillet F, Bernard O, Labrune P, Baussan C. Hereditary fructose intolerance: frequency and spectrum mutations of the aldolase B gene in a large patients cohort from France &#x02013; identification of eight new mutations. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">94</span>:443–7.</span> [<a href="/pubmed/18541450" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18541450</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.dursun.2001.523">Dursun A, Kalkano&#x0011f;lu HS, Co&#x0015f;kun T, Tokatli A, Bittner R, Ko&#x000e7;ak N, Y&#x000fc;ce A, Ozalp I, Boehme HJ. Mutation analysis in Turkish patients with hereditary fructose intolerance. <span><span class="ref-journal">J Inherit Metab Dis. </span>2001;<span class="ref-vol">24</span>:523–6.</span> [<a href="/pubmed/11757579" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11757579</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.esposito.2010.1294">Esposito G, Imperato MR, Ieno L, Sorvillo R, Benigno V, Parenti G, Parini R, Vitagliano L, Zagari A, Salvatore F. Hereditary fructose intolerance: functional study of two novel ALDOB natural variants and characterization of a partial gene deletion. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:1294–303.</span> [<a href="/pubmed/20848650" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20848650</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.ferri.2012.31">Ferri L, Caciotti A, Cavicchi C, Rigoldi M, Parini R, Caserta M, Chibbaro G, Gasperini S, Procopio E, Donati MA, Guerrini R, Morrone A. Integration of PCR-sequencing analysis with multiplex ligation-dependent probe amplification for diagnosis of hereditary fructose intolerance. <span><span class="ref-journal">JIMD Rep. </span>2012;<span class="ref-vol">6</span>:31–7.</span> [<a href="/pmc/articles/PMC3565637/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3565637</span></a>] [<a href="/pubmed/23430936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23430936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.fiocchi.2014.e602">Fiocchi A, Dionisi-Vici C, Cotugno G, Koch P, Dahdah L. Fruit-induced FPIES masquerading as hereditary fructose intolerance. <span><span class="ref-journal">Pediatrics. </span>2014;<span class="ref-vol">134</span>:e602–5.</span> [<a href="/pubmed/25002667" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25002667</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.froesch.1963.151">Froesch ER, Wolf HP, Baitsch H, Prader A, Labhart A. Hereditary fructose intolerance. An inborn defect of hepatic fructose-1-phosphate splitting aldolase. <span><span class="ref-journal">Am J Med. </span>1963;<span class="ref-vol">34</span>:151–67.</span> [<a href="/pubmed/13959929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13959929</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.gruchota.2006.376">Gruchota J, Pronicka E, Korniszewski L, Stolarski B, Pollak A, Rogaszewska M, P&#x00142;oski R. Aldolase B mutations and prevalence of hereditary fructose intolerance in a Polish population. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">87</span>:376–8.</span> [<a href="/pubmed/16406649" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16406649</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.hommes.1993.788s">Hommes FA. Inborn errors of fructose metabolism. <span><span class="ref-journal">Am J Clin Nutr. </span>1993;<span class="ref-vol">58</span>:788S–95S.</span> [<a href="/pubmed/8213611" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8213611</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.hoskov_.1977.63">Hoskov&#x000e1; A, Mrskos A. Haemorrhagic diathesis as a possible early sign of hereditary fructose intolerance. <span><span class="ref-journal">Eur J Pediatr. </span>1977;<span class="ref-vol">127</span>:63–5.</span> [<a href="/pubmed/606560" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 606560</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.jaeken.1996.764">Jaeken J, Pirard M, Adamowicz M, Pronicka E, van Schaftingen E. Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance. <span><span class="ref-journal">Pediatr Res. </span>1996;<span class="ref-vol">40</span>:764–6.</span> [<a href="/pubmed/8910943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8910943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.james.1996.837">James CL, Rellos P, Ali M, Heeley AF, Cox TM. Neonatal screening for hereditary fructose intolerance: frequency of the most common mutant aldolase B allele (A149P) in the British population. <span><span class="ref-journal">J Med Genet. </span>1996;<span class="ref-vol">33</span>:837–41.</span> [<a href="/pmc/articles/PMC1050763/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050763</span></a>] [<a href="/pubmed/8933337" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8933337</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.krawczy_ski.1994.702">Krawczy&#x00144;ski M, Targo&#x00144;ska B, Kostrzewa-Szymiec D, Walkowiak J, Cichy W. Congenital fructose intolerance diagnosed in a 13-year-old boy. <span><span class="ref-journal">Wiad Lek. </span>1994;<span class="ref-vol">47</span>:702–4.</span> [<a href="/pubmed/7571625" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7571625</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.lazarin.2013.178">Lazarin GA, Haque IS, Nazareth S, Iori K, Patterson AS, Jacobson JL, Marshall JR, Seltzer WK, Patrizio P, Evans EA, Srinivasan BS. An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals. <span><span class="ref-journal">Genet Med. </span>2013;<span class="ref-vol">15</span>:178–86.</span> [<a href="/pmc/articles/PMC3908551/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3908551</span></a>] [<a href="/pubmed/22975760" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22975760</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.leonardi.1986.189">Leonardi S, Fischer A, Di Dio R, D'Agata A, Musumeci S. Neonatal cholestasis: clinical and diagnostic setting. <span><span class="ref-journal">Pediatr Med Chir. </span>1986;<span class="ref-vol">8</span>:189–200.</span> [<a href="/pubmed/3786181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3786181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.levin.1963.220">Levin B, Oberholzer VG, Snodgrass GJ, Stimmler L, Wilmers MJ. Fructosaemia: an inborn error of fructose metabolism. <span><span class="ref-journal">Arch Dis Child. </span>1963;<span class="ref-vol">38</span>:220–30.</span> [<a href="/pmc/articles/PMC2019039/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2019039</span></a>] [<a href="/pubmed/13930101" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13930101</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.locher.1987.194">Locher S. Acute liver and kidney failure following sorbitol infusion in a 28-year-old patient with undiagnosed fructose intolerance. <span><span class="ref-journal">Anasth Intensivther Notfallmed. </span>1987;<span class="ref-vol">22</span>:194–7.</span> [<a href="/pubmed/3116878" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3116878</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.lu.2001.30407">Lu M, Holliday LS, Zhang L, Dunn WA Jr, Gluck SL. Interaction between aldolase and vacuolar H+-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:30407–13.</span> [<a href="/pubmed/11399750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11399750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.maggiore.1982.169">Maggiore G, Borgna-Pignatti C. Disseminated intravascular coagulation associated with hereditary fructose intolerance. <span><span class="ref-journal">Am J Dis Child. </span>1982;<span class="ref-vol">136</span>:169–70.</span> [<a href="/pubmed/7064932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7064932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.malay.2005.135">Malay AD, Allen KN, Tolan DR. Structure of the thermolabile mutant aldolase B, A149P: molecular basis of hereditary fructose intolerance. <span><span class="ref-journal">J Mol Biol. </span>2005;<span class="ref-vol">347</span>:135–44.</span> [<a href="/pubmed/15733923" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15733923</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.mandel.1990.267">Mandel H, Gozal D, Aizin A, Tavori S, Jaffe M. Haemophagocytosis in hereditary fructose intolerance: a diagnostic dilemma. <span><span class="ref-journal">J Inherit Metab Dis. </span>1990;<span class="ref-vol">13</span>:267–9.</span> [<a href="/pubmed/2122082" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2122082</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.marks.1989.362">Marks F, Ordorica S, Hoskins I, Young BK. Congenital hereditary fructose intolerance and pregnancy. <span><span class="ref-journal">Am J Obstet Gynecol. </span>1989;<span class="ref-vol">160</span>:362–3.</span> [<a href="/pubmed/2916618" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2916618</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.marthaler.1967.597">Marthaler TM, Froesch ER. Hereditary fructose intolerance. Dental status of eight patients. <span><span class="ref-journal">Br Dent J. </span>1967;<span class="ref-vol">123</span>:597–9.</span> [<a href="/pubmed/5234813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5234813</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.mass.1966.516">Mass RE, Smith WR, Walsh JR. The association of hereditary fructose intolerance and renal tubular acidosis. <span><span class="ref-journal">Am J Med Sci. </span>1966;<span class="ref-vol">251</span>:516–23.</span> [<a href="/pubmed/5933765" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5933765</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.michelakakis.2009.81">Michelakakis H, Moraitou M, Mavridou I, Dimitriou E. Plasma lysosomal enzyme activities in congenital disorders of glycosylation, galactosemia and fructosemia. <span><span class="ref-journal">Clin Chim Acta. </span>2009;<span class="ref-vol">401</span>:81–3.</span> [<a href="/pubmed/19100247" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19100247</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.mock.1983.764">Mock DM, Perman JA, Thaler M, Morris RC Jr. Chronic fructose intoxication after infancy in children with hereditary fructose intolerance. A cause of growth retardation. <span><span class="ref-journal">N Engl J Med. </span>1983;<span class="ref-vol">309</span>:764–70.</span> [<a href="/pubmed/6888454" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6888454</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.morris.1968.1648">Morris RC Jr. An experimental renal acidification defect in patients with hereditary fructose intolerance. <span><span class="ref-journal">J Clin Invest. </span>1968;<span class="ref-vol">47</span>:1648–63.</span> [<a href="/pmc/articles/PMC297322/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC297322</span></a>] [<a href="/pubmed/5658593" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5658593</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.m_ller.2003.276">M&#x000fc;ller P, Meier C, B&#x000f6;hme HJ, Richter T. Fructose breath hydrogen test--is it really a harmless diagnostic procedure? <span><span class="ref-journal">Dig Dis. </span>2003;<span class="ref-vol">21</span>:276–8.</span> [<a href="/pubmed/14571104" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14571104</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.newbrun.1980.619">Newbrun E, Hoover C, Mettraux G, Graf H. Comparison of dietary habits and dental health of subjects with hereditary fructose intolerance and control subjects. <span><span class="ref-journal">J Am Dent Assoc. </span>1980;<span class="ref-vol">101</span>:619–26.</span> [<a href="/pubmed/6934214" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6934214</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.oberhaensli.1987.931">Oberhaensli RD, Rajagopalan B, Taylor DJ, Radda GK, Collins JE, Leonard JV, Schwarz H, Herschkowitz N. Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy. <span><span class="ref-journal">Lancet. </span>1987;<span class="ref-vol">2</span>:931–4.</span> [<a href="/pubmed/2889861" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2889861</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.odi_vre.1978.605">Odi&#x000e8;vre M, Gentil C, Gautier M, Alagille D. Hereditary fructose intolerance in childhood. Diagnosis, management, and course in 55 patients. <span><span class="ref-journal">Am J Dis Child. </span>1978;<span class="ref-vol">132</span>:605–8.</span> [<a href="/pubmed/655145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 655145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.paolella.2012.64">Paolella G, Pisano P, Albano R, Cannaviello L, Mauro C, Esposito G, Vajro P. Fatty liver disease and hypertransaminasemia hiding the association of clinically silent Duchenne muscular dystrophy and hereditary fructose intolerance. <span><span class="ref-journal">Ital J Pediatr. </span>2012;<span class="ref-vol">38</span>:64.</span> [<a href="/pmc/articles/PMC3502262/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3502262</span></a>] [<a href="/pubmed/23114028" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23114028</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.pronicka.2007.101">Pronicka E, Adamowicz M, Kowalik A, P&#x00142;oski R, Radomyska B, Rogaszewska M, Rokicki D, Sykut-Cegielska J. Elevated carbohydrate-deficient transferrin (CDT) and its normalization on dietary treatment as a useful biochemical test for hereditary fructose intolerance and galactosemia. <span><span class="ref-journal">Pediatr Res. </span>2007;<span class="ref-vol">62</span>:101–5.</span> [<a href="/pubmed/17515832" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17515832</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.quintana.2009.s273">Quintana E, Sturiale L, Montero R, Andrade F, Fernandez C, Couce ML, Barone R, Aldamiz-Echevarria L, Ribes A, Artuch R, Briones P. Secondary disorders of glycosylation in inborn errors of fructose metabolism. <span><span class="ref-journal">J Inherit Metab Dis. </span>2009;<span class="ref-vol">32</span> Suppl 1:S273–8.</span> [<a href="/pubmed/19768653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19768653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.sachs.1993.56">Sachs M, Asskali F, F&#x000f6;rster H, Encke A. Repeated perioperative administration of fructose and sorbitol in a female patient with hereditary fructose intolerance. <span><span class="ref-journal">Z Ernahrungswiss. </span>1993;<span class="ref-vol">32</span>:56–66.</span> [<a href="/pubmed/8484270" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8484270</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.s_nchezguti_rrez.2002.e56">S&#x000e1;nchez-Guti&#x000e9;rrez JC, Benlloch T, Leal MA, Samper B, Garc&#x000ed;a-Ripoll I, Fel&#x000ed;u JE. Molecular analysis of the aldolase B gene in patients with hereditary fructose intolerance from Spain. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:e56.</span> [<a href="/pmc/articles/PMC1735221/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735221</span></a>] [<a href="/pubmed/12205126" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12205126</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.santer.2005.594">Santer R, Rischewski J, von Weihe M, Niederhaus M, Schneppenheim S, Baerlocher K, Kohlsch&#x000fc;tter A, Muntau A, Posselt HG, Steinmann B, Schneppenheim R. The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">25</span>:594.</span> [<a href="/pubmed/15880727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15880727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.sax_n.1989.150">Sax&#x000e9;n L, Jousimies-Somer H, Kaisla A, Kanervo A, Summanen P, Sipil&#x000e4; I. Subgingival microflora, dental and periodontal conditions in patients with hereditary fructose intolerance. <span><span class="ref-journal">Scand J Dent Res. </span>1989;<span class="ref-vol">97</span>:150–8.</span> [<a href="/pubmed/2704977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2704977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.schrodi.2015.659">Schrodi SJ, DeBarber A, He M, Ye Z, Peissig P, Van Wormer JJ, Haws R, Brilliant MH, Steiner RD. Prevalence estimation for monogenic autosomal recessive diseases using population-based genetic data. <span><span class="ref-journal">Hum Genet. </span>2015;<span class="ref-vol">134</span>:659–69.</span> [<a href="/pubmed/25893794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25893794</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.seegmiller.1990.8326">Seegmiller JE, Dixon RM, Kemp GJ, Angus PW, McAlindon TE, Dieppe P, Rajagopalan B, Radda GK. Fructose-induced aberration of metabolism in familial gout identified by 31P magnetic resonance spectroscopy. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1990;<span class="ref-vol">87</span>:8326–30.</span> [<a href="/pmc/articles/PMC54948/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC54948</span></a>] [<a href="/pubmed/2236043" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2236043</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.steinmann.2011">Steinmann B, Santer R. Disorders of fructose metabolism. In: Saudubray JM, van den Berghe G, Walter J, eds. <em>Inherited Metabolic Diseases</em>. 5 ed. Berlin, Germany: Springer. 2011:159-62.</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.thabet.2002.581">Thabet F, Durand P, Chevret L, Fabre M, Debray D, Brivet M, Devictor D. Severe Reye syndrome: report of 14 cases managed in a pediatric intensive care unit over 11 years. <span><span class="ref-journal">Arch Pediatr. </span>2002;<span class="ref-vol">9</span>:581–6.</span> [<a href="/pubmed/12108311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12108311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.van_den_berghe.1973.637">Van Den Berghe G, Hue L, Hers HG. Effect of administration of the fructose on the glycogenolytic action of glucagon. An investigation of the pathogeny of hereditary fructose intolerance. <span><span class="ref-journal">Biochem J. </span>1973;<span class="ref-vol">134</span>:637–45.</span> [<a href="/pmc/articles/PMC1177852/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1177852</span></a>] [<a href="/pubmed/16742826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16742826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.w_ssmann.2000.108">W&#x000f6;ssmann W, Wiemann J, K&#x000f6;rber F, Gortner L. Hereditary fructose intolerance (HFI) as cause of isolated gamma GT rise in a 5-year old boy with hepatomegaly. <span><span class="ref-journal">Klin Padiatr. </span>2000;<span class="ref-vol">212</span>:108–9.</span> [<a href="/pubmed/10916780" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10916780</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hfi.REF.yang.2000.218">Yang TY, Chen HL, Ni YH, Hwu WL, Chang MH. Hereditary fructose intolerance presenting as Reye's-like syndrome: report of one case. <span><span class="ref-journal">Acta Paediatr Taiwan. </span>2000;<span class="ref-vol">41</span>:218–20.</span> [<a href="/pubmed/11021009" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11021009</span></a>]</div></li></ul></div></div><div id="hfi.Chapter_Notes"><h2 id="_hfi_Chapter_Notes_">Chapter Notes</h2><div id="hfi.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>17 December 2015 (me) Review posted live</div></li><li class="half_rhythm"><div>15 July 2015 (jwa) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK333439</span><span class="label">PMID: <a href="/pubmed/26677512" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">26677512</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/folate-mal/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/deafness-overview/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK333439&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK333439/?report=reader">PubReader</a></li><li><a href="/books/NBK333439/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK333439" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK333439" style="display:none" title="Cite this Page"><div class="bk_tt">Baker P II, Ayres L, Gaughan S, et al. Hereditary Fructose Intolerance. 2015 Dec 17. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK333439/pdf/Bookshelf_NBK333439.pdf">PDF version of this page</a> (468K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#hfi.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#hfi.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#hfi.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#hfi.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#hfi.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#hfi.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#hfi.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#hfi.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#hfi.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#hfi.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#hfi.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=229[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ALDOB</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4185570" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4185570" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4185570" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4185570" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31804789" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fructose-1,6-Bisphosphatase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fructose-1,6-Bisphosphatase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bijarnia-Mahay S, Bhatia S, Arora V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593918" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shchelochkov OA, Carrillo N, Venditti C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301489" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bali DS, Chen YT, Austin S, Goldstein JL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301360" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrin Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Citrin Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Saheki T, Song YZ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301691" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Classic Galactosemia and Clinical Variant Galactosemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Classic Galactosemia and Clinical Variant Galactosemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Berry GT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=26677512" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=26677512" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04295475f66d18aae84a95">Hereditary Fructose Intolerance - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Hereditary Fructose Intolerance - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:30:29-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C77A8E041FB4100000000042D01A3&amp;ncbi_session=CE8C77A8E0429541_1069SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK333439%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK333439&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK333439/&amp;ncbi_pagename=Hereditary Fructose Intolerance - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C77A8E0429541_1069SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>